Abstract:Madalina Macrea, 1 Atul Malhotra, 2 Richard ZuWallack, 3 Krisann Oursler, 4 Richard Casaburi 5 1 Department of Pulmonary and Sleep Medicine, Salem Veterans Affairs Medical Center, University of Virginia, Charlottesville, VA, USA; 2 Department of Pulmonary, Critical Care and Sleep Medicine, University of California at San Diego, San Diego, CA, USA; 3 Department of Pulmonary, Critical Care, and Sleep Medicine St. Francis Hospital, Hartford, CT, USA; 4 Department of Geriatrics and Infection Disease, Salem Veterans Affairs Medical Center, Carilion Virginia Tech School of Medicine, Roanoke, VA, USA; 5 Division of Respiratory and Critical Care Physiology and Medicine, Lundquist Institute for Biomedical Innovation at Harbor-University of California at Los Angeles Medical Center, Torrance, CA, USA Correspondence: Madalina Macrea, Department of Pulmonary and Sleep Medicine, Salem Veterans Affairs Medical Center, Salem, VA, 24153, USA, Tel +1 540 982 2463 ext 6609, Email Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in Overlap Syndrome (OS), the co-occurrence of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease. Clustering of patients in subgroups with similar pre-clinical manifestations (ie, endothelial dysfunction) may identify relevant therapeutic phenotype categories for patients with OS who are at high risk of CVD. We therefore conducted a cross-sectional pilot study of endothelial function in 7 patients with OS (Forced Expiratory Volume in 1 second/Forced Vital Capacity < 0.7) on continuous positive airway pressure therapy (n = 7) to assess the relationship between FMD and physical activity. We found a strong association between FMD and step counts (rho = 0.77, p = 0.04); and FMD and moderate physical activity (rho = 0.9, p = 0.005). Further, larger studies are needed to confirm that FMD may identify patients with OS at high risk of CVD who benefit from increased physical activity. Keywords: flow-mediated dilation, chronic obstructive pulmonary disease, obstructive sleep apnea, physical activity Both chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are recognized as complex and heterogeneous disorders, ranging from mild symptoms to severe comorbid conditions. The term "Overlap Syndrome" (OS) is used to describe the simultaneous presence of both COPD and OSA in the same patient. Despite variations in clinical spectrum, the treatment decisions in OS are based on the forced expiratory volume in 1 second (FEV 1 ) and the apnea hypopnea index (AHI) only and lack stratification by other clinical characteristics. In contrast, classification of patients with OS into phenotypes with similar clinical manifestations may identify treatments aimed at reducing cardiovascular risk, in addition to the standard of care therapies that include inhaled medications and continuous positive airway pressure (CPAP). Phenotypes that predict CVD specifically in OS are not known. Table 1 Participants' Characteristics Vascular endothelial dysfunction is a known pathophysiologic antecedent of clinical atherosclerosis and a valuable early therapeutic target for reducing CVD risk. 1 Studies suggest that patients with OS have endothelial dysfunction that can improve with short term (3 months) CPAP therapy. 2 It is unclear if endothelial dysfunction persists in most OS patients who are on long-term CPAP, which may explain the lack of CPAP treatment effects on CVD events in recent randomized trials. 3 The endothelial function can be measured by ultrasound, called flow-mediated vasodilation (FMD), which measures the increase in brachial artery diameter that occurs with inflation of an upper arm blood pressure cuff. Habitual physical activity (PA) attenuates endothelial aging through increased endothelial shear stress and function. 4 A meta-analysis showed that individuals who engage in the equivalent of 150 minutes per week of moderate intensity PA have 20% decreased risk of developing coronary artery disease compared to those who are sedentary. 5 Despite that finding, patients with OS have low levels of PA, a mean of 2000 steps per day, which is far below the recommended threshold of 10, 000 steps per day. 6 Thus, a physically active lifestyle in addition to CPAP may attenuate the development of CVD in patients with OS and endothelial dysfunction. In summary, the objective of our study was to investigate endothelial dysfunction and its association with PA in patients with OS treated with long-term CPAP (mean length of CPAP therapy of 78 months), with the goal of identifying relevant prognostic and therapeutic phenotype categories for this population at high risk of CVD. Parti -Abstract Truncated-

Abstract 13798: Obstructive Sleep Apnea Severity and Abnormal Right Ventricular Flow Reserve in Adult OSA Patients Who Received Rubidium-82 Cardiac PET Perfusion Imaging

Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension

Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension

Left ventricular remodeling and systolic function changes in patients with obstructive sleep apnea: a comprehensive contrast-enhanced cardiac magnetic resonance study

Abstract 15564: Transcriptional Profiling Unveils New Molecular Subgroups of Adaptive and Maladaptive Right Ventricular Remodeling in Pulmonary Hypertension

Tissue-Based Predictors of Impaired Right Ventricular Strain in Coronary Artery Disease: A Multicenter Stress Perfusion Study

1042 Assessment of left ventricular systolic function in obstructive sleep apnea with automatic function imaging and its relation relation with hypoxia

Hemodynamic Insights into Combined Fractional Flow Reserve and Instantaneous Wave-Free Ratio Assessment Through Quantitative [15O]H2O PET Myocardial Perfusion Imaging

Evaluation of right ventricular performance and impact of continuous positive airway pressure therapy in patients with obstructive sleep apnea living at high altitude

Brain Bioenergetics During Resting Wakefulness Are Related to Neurobehavioral Deficits in Severe Obstructive Sleep Apnea: a 31P Magnetic Resonance Spectroscopy Study

Diagnostic value of regional myocardial flow reserve measurements using Rubidium-82 PET : Disclosures none

Impact of Absolute Myocardial Blood Flow Quantification on the Diagnostic Performance of PET-Based Perfusion Scans Using 82Rubidium

A Cross-Sectional Study Evaluating the Association of Brachial Artery Flow Mediated Vasodilation with Physical Activity Measured by Accelerometry in Patients with the Overlap of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension

0556 Sex-Specific Relationship Between Anxiety and Autonomic Nervous System Dysfunction in Obstructive Sleep Apnea

Effect of Obstructive Sleep Apnea and Positive Airway Pressure Therapy on Cardiac Remodeling as Assessed by Cardiac Biomarker and Magnetic Resonance Imaging in Nonobese and Obese Adults

Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension

Multimodal echocardiography for assessing whether left ventricular geometry affects right atrial phasic function in patients with obstructive sleep apnea syndrome: A cross‐sectional observational study

Cardiac structural and functional changes in OSAHS patients with heart failure with preserved ejection fraction and atrial fibrillation

Association of Polysomnographic Sleep Parameters With Neuroimaging Biomarkers of Cerebrovascular Disease in Older Adults With Sleep Apnea

Cardiac autonomic dysfunction and structural remodeling: the potential mechanism to mediate the relationship between obstructive sleep apnea and cardiac arrhythmias